[Problem] The present invention addresses the problem of providing a hemostatic pharmaceutical composition which has higher usability compared with conventional hemostatic agents each utilizing a biogel, and which can be formed into a transparent and homogeneous hydrogel in a broad pH range. [Solution] A hemostatic pharmaceutical composition containing a (sugar chain)-polypeptide complex is provided, said hemostatic pharmaceutical composition being characterized in that the polypeptide in the (sugar chain)-polypeptide complex is a polypeptide comprising an amino acid sequence in which a polar amino acid residue and a non-polar amino acid residue are arranged alternately, wherein one or multiple sugar chains are bound to the polypeptide.
